Global Non-Invasive Prenatal Testing Market 2016-2020

Publisher Name :
Date: 30-Aug-2016
No. of pages: 70
Inquire Before Buying

NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.

The analysts forecast global non-invasive prenatal testing (NIPT) market to grow at a CAGR of 17.44% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing (NIPT) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of testing products.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • BGI Genomics

  • Illumina

  • LifeCodexx

  • Natera

  • Sequenom


Other prominent vendors


  • Ariosa Diagnostics

  • Berry Genomics

  • CombiMatrix

  • F. Hoffmann-La Roche

  • Genpharm Services

  • Laboratory Corporation of America Holdings

  • LifeLabs Genetics

  • Quest Diagnostics

  • Safembryo

  • Sengenics


Market driver


  • Incidence of fetal chromosomal disorders in newborns

  • For a full, detailed list, view our report


Market challenge


  • Limited consumer options and lack of effective product differentiation

  • For a full, detailed list, view our report


Market trend


  • Increase in partnerships and collaborations

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2020 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Global Non-Invasive Prenatal Testing Market 2016-2020

Table of Contents

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Market segmentation by testing product
Global NIPT market for MaterniT21 Plus test
Global NIPT market for NIFTY test
Global NIPT market for Harmony test
Global NIPT market for Bambni test
Global NIPT market for Verifi test
Global NIPT market for Panorama test
Global NIPT market for PrenaTest

PART 07: Market segmentation by end-user
Hospitals
Diagnostic clinical laboratories
Research laboratories and academia

PART 08: Geographical segmentation
NIPT market in Americas
NIPT market in EMEA
NIPT market in APAC

PART 09: Market drivers
Child-bearing at advanced maternal age
Incidence of fetal chromosomal disorders in newborns
Advantages of NIPTs

PART 10: Impact of drivers

PART 11: Market challenges
Pregnancy termination due to disability
Limitations of prenatal cell-free DNA screening
Limited consumer options and lack of effective product differentiation

PART 12: Impact of drivers and challenges

PART 13: Market trends
Increased volumes of prenatal care counselling in hospitals
Bioinformatics tools combined with DNA sequencing for NIPTs
Increase in partnerships and collaborations

PART 14: Vendor landscape
Competitive scenario

PART 15: Major vendors
BGI Genomics
Illumina
LifeCodexx
Natera
Sequenom
Other prominent vendors

PART 16: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Global NIPT market ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global NIPT market segmentation by testing product 2015
Exhibit 05: Global NIPT market segmentation by testing product 2020
Exhibit 06: Global NIPT market for Maternit21 Plus test: Metric analysis 2016-2020
Exhibit 07: Global NIPT market for Maternit21 Plus test 2015-2020 ($ millions)
Exhibit 08: Global NIPT market for NIFTY test: Metric analysis 2016-2020
Exhibit 09: Global NIPT market for NIFTY test 2015-2020 ($ millions)
Exhibit 10: Global NIPT market for Harmony test: Metric analysis 2016-2020
Exhibit 11: Global NIPT market for Harmony test 2015-2020 ($ millions)
Exhibit 12: Global NIPT market for Bambni test: Metric analysis 2016-2020
Exhibit 13: Global NIPT market for Bambni test 2015-2020 ($ millions)
Exhibit 14: Sensitivity and specificity of Verifi test
Exhibit 15: Global NIPT market for Verifi test: Metric analysis 2016-2020
Exhibit 16: Global NIPT market for Verifi test 2015-2020 ($ millions)
Exhibit 17: Global NIPT market for Panorama test: Metric analysis 2016-2020
Exhibit 18: Global NIPT market for Panorama test 2015-2020 ($ millions)
Exhibit 19: Detection rate of Panorama test
Exhibit 20: Global NIPT market for PrenaTest: Metric analysis 2016-2020
Exhibit 21: Global NIPT market for PrenaTest 2015-2020 ($ millions)
Exhibit 22: Global NIPT market segmentation by geography 2015
Exhibit 23: Global NIPT market segmentation by geography 2020
Exhibit 24: NIPT market in Americas 2015-2020 ($ millions)
Exhibit 25: NIPT market in EMEA 2015-2020 ($ millions)
Exhibit 26: NIPT market in APAC 2015-2020 ($ millions)
Exhibit 27: Non-invasive and invasive prenatal tests
Exhibit 28: Impact of drivers
Exhibit 29: Impact of drivers and challenges
Exhibit 30: Global NIPT market: Competitive landscape analysis 2015
Exhibit 31: BGI Genomics: Metrics analysis
Exhibit 32: Illumina: Metrics analysis
Exhibit 33: LifeCodexx: Metrics analysis
Exhibit 34: Natera: Metrics analysis
Exhibit 35: Sequenom: Metrics analysis
Exhibit 36: Other prominent vendors

  • Global Rapid Medical Diagnostic Kits Market Research Report 2017
    Published: 21-Nov-2017        Price: US 2900 Onwards        Pages: 124
    In this report, the global Rapid Medical Diagnostic Kits market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Rapid Medical Diagnostic Kits in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global In-Vitro Diagnostics (IVD) Market Size, Status and Forecast 2022
    Published: 17-Nov-2017        Price: US 3300 Onwards        Pages: 100
    This report studies the global In-Vitro Diagnostics (IVD) market, analyzes and researches the In-Vitro Diagnostics (IVD) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Roche - Siemens - Danaher - Abbott - BD - Alere - SYSMEX - BioMerieux - J&J - BIO-RAD - Hologic - KHB Market segment by Re......
  • Therapeutic Drug Monitoring (TDM) Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 313-page report from VPGMarketResearch.com contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and m......
  • France Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Germany Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Italy Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • Japan Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2750 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/......
  • Spain Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation ReviewReview
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • UK Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Proca......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs